BET-S190-132 | PAb to E-Tag, from goat (Agarose Immobilized) | 0.1 mg |
BET-S190-134 | PAb to S-Tag, from goat (Agarose Immobilized) | 0.1 mg |
BET-S190-136 | PAb to HSV, from goat (Agarose Immobilized) | 0.1 mg |
BET-S300-000 | PAb to Breast Cancer Gene 1 (human) (exon 26) (BL319), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-005 | PAb to Breast Cancer Gene 2 (human) (exon 27) (BL320), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-010 | PAb to Mitotic Kinesin-like Protein 1 (human) (exon 2), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-015 | PAb to MLH1 (human) (exon 20) (BL322), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-020 | PAb to MSH2 (human) (exon 1) (BL323), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-025 | PAb to Glucocorticoid Receptor Interacting Protein-1 (human) (exon 9), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-030 | PAb to RFX5 (human) (exon 5) (BL326), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-035 | PAb to RFXANK (human) (exon 11) (BL328), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-040 | PAb to Regulatory Factor X Associated Protein (human) (exon 1) (BL327), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-055 | PAb to SMC1 (human) (exon 26) (BL308), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-060 | PAb to SMC3 (human) (exon 28) (BL313), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-065 | PAb to XRCC1 (human) (exon 17) (BL316), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-070 | PAb to Aurora A (human) (exon 5) (BL333), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-075 | PAb to CDC25a (human) (exon 7) (BL329), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-076 | PAb to CDC25a (human) (exon 9) (BL330), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-080 | PAb to Rad21 (human) (exon 14) (BL331), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-085 | PAb to PMS2 (human) (exon 2) (BL324), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-105 | PAb to Menin (BL342), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-135 | PAb to Ataxia telangiectasia Mutated (exon 36/37) (BL114G), from goat (Agarose Immobilized) | 0.1 mg |
BET-S300-136 | PAb to Ataxia telangiectasia Mutated (exon 53) (BL116G), from goat (Agarose Immobilized) | 0.1 mg |
BET-S300-404 | PAb to Glucose-6-Phosphate Dehydrogenase (human) (exon 6/7) (BL341), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-503 | PAb to mTOR (exon 65/6) (BL897), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-504 | PAb to mTOR (exon 5/6) (BL898), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-507 | PAb to AMPK alpha1 (exon 8) (BL809), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-S300-508 | PAb to AMPK alpha2 (exon 7) (BL810), from rabbit (Agarose Immobilized) | 0.1 mg |
BET-WB120 | ReliaBLOT™ IP/Western Blot Reagents Kit | 20 miniblots |
BET-WB120T | ReliaBLOT™ IP/Western Blot Reagents Kit | 5 miniblots |
BET-A300-575A | PAb to S6K2 (300-350) (human) (BL2624), from rabbit (purified) | 0.1 mg |
BET-A300-576A | PAb to S6K2 (430-482) (human) (BL2625), from rabbit (purified) | 0.02 mg |
BET-A300-577A | PAb to PITX1 (50-100) (human) (BL2505), from rabbit (purified) | 0.1 mg |
BET-A300-578A | PAb to Neurofibromin 2 (Isoform 1) (550-595) (human) (BL2776), from rabbit (purified) | 0.1 mg |
BET-A300-579A | PAb to Neurofibromin 2 (Isoform 2) (550-590) (human) (BL2777), from rabbit (purified) | 0.1 mg |
BET-A300-580A | PAb to WASP (1-50) (human) (BL2483), from rabbit (purified) | 0.1 mg |
BET-A300-581A | PAb to WASP (400-462) (human) (BL2485), from rabbit (purified) | 0.02 mg |
BET-A300-582A | PAb to NonO (1-50) (human) (BL2552), from rabbit (purified) | 0.02 mg |
BET-A300-583A | PAb to RPS6 (human) (phosphorylated) (pSer235) (BL2654), from rabbit (purified) | 0.1 mg |
BET-A300-584A | PAb to RPS6 (human) (phosphorylated) (pSer235/pSer236) (BL2656), from rabbit (purified) | 0.02 mg |
BET-A300-585A | PAb to PRKRIR (25-75) (BL2254), from rabbit (purified) | 0.02 mg |
BET-A300-586A | PAb to PRKRIR (150-200) (BL2255), from rabbit (purified) | 0.02 mg |
BET-A300-587A | PAb to NonO (350-400) (human) (BL2553), from rabbit (purified) | 0.02 mg |
BET-A300-588A | PAb to Valosin-containing Protein (1-50) (BL2519), from rabbit (purified) | 0.02 mg |
BET-A300-589A | PAb to Valosin-containing Protein (750-806) (BL2520), from rabbit (purified) | 0.02 mg |
BET-A300-590A | PAb to Matrin-3 (475-500) (BL2525), from rabbit (purified) | 0.1 mg |
BET-A300-591A | PAb to Matrin-3 (800-847) (BL2526), from rabbit (purified) | 0.02 mg |
BET-A300-592A | PAb to Sec23IP (1-50) (human) (BL2564), from rabbit (purified) | 0.02 mg |
BET-A300-593A | PAb to Sec23IP (350-400) (human) (BL2565), from rabbit (purified) | 0.02 mg |
BET-A300-594A | PAb to Sec23IP (950-1000) (human) (BL2566), from rabbit (purified) | 0.02 mg |
BET-A300-595A | PAb to AF9 (200-250) (human) (BL2310), from rabbit (purified) | 0.02 mg |
BET-A300-596A | PAb to AF9 (250-300) (human) (BL2311), from rabbit (purified) | 0.1 mg |
BET-A300-597A | PAb to AF9 (525-568) (human) (BL2313), from rabbit (purified) | 0.1 mg |
BET-A300-598A | PAb to Estrogen Receptor alpha (human) (phosphorylated) (pSer305) (BL1665), from rabbit (purified) | 0.1 mg |
BET-A300-599A | PAb to GNL3 (1-50) (BL2856), from rabbit (purified) | 0.02 mg |
BET-A300-600A | PAb to GNL3 (500-549) (BL2858), from rabbit (purified) | 0.02 mg |
BET-A300-601A | PAb to CAP-D2 (1350-1401) (human) (BL2932), from rabbit (purified) | 0.02 mg |
BET-A300-602A | PAb to CAP-G (950-1015) (human) (BL2936), from rabbit (purified) | 0.02 mg |
BET-A300-603A | PAb to CAP-H (700-741) (human) (BL2940), from rabbit (purified) | 0.02 mg |
BET-A300-604A | PAb to CAP-D3 (1450-1507) (human) (BL2944), from rabbit (purified) | 0.02 mg |
BET-A300-614A | PAb to SKIV2L2 (100-150) (BL2548), from rabbit (purified) | 0.02 mg |
BET-A300-615A | PAb to SKIV2L2 (650-700) (human) (BL2549), from rabbit (purified) | 0.1 mg |
BET-A300-616A | PAb to DDX10 (500-550) (human) (BL3003), from rabbit (purified) | 0.1 mg |
BET-A300-617A | PAb to DDX10 (825-875) (human) (BL3004), from rabbit (purified) | 0.02 mg |
BET-BP300-575 | Blocking Peptide for PAb to S6K2 (300-350) (human) (BL2624), from rabbit (purified) (Prod. No. BET-A300-575A) | 50 ug |
BET-BP300-576 | Blocking Peptide for PAb to S6K2 (430-482) (human) (BL2625), from rabbit (purified) (Prod. No. BET-A300-576A) | 50 ug |
BET-BP300-577 | Blocking Peptide for PAb to PITX1 (50-100) (human) (BL2505), from rabbit (purified) (Prod. No. BET-A300-577A) | 50 ug |
BET-BP300-578 | Blocking Peptide for PAb to Neurofibromin 2 (Isoform 1) (550-595) (human) (BL2776), from rabbit (purified) (Prod. No. BET-A300-578A) | 50 ug |
BET-BP300-579 | Blocking Peptide for PAb to Neurofibromin 2 (Isoform 2) (550-590) (human) (BL2777), from rabbit (purified) (Prod. No. BET-A300-579A) | 50 ug |
BET-BP300-580 | Blocking Peptide for PAb to WASP (1-50) (human) (BL2483), from rabbit (purified) (Prod. No. BET-A300-580A) | 50 ug |
BET-BP300-581 | Blocking Peptide for PAb to WASP (400-462) (human) (BL2485), from rabbit (purified) (Prod. No. BET-A300-581A) | 50 ug |
BET-BP300-582 | Blocking Peptide for PAb to NonO (1-50) (human) (BL2552), from rabbit (purified) (Prod. No. BET-A300-582A) | 50 ug |
BET-BP300-583P | Blocking Peptide for PAb to RPS6 (human) (phosphorylated) (pSer235) (BL2654), from rabbit (purified) (Prod. No. BET-A300-583A) | 50 ug |
BET-BP300-584P | Blocking Peptide for PAb to RPS6 (human) (phosphorylated) (pSer235/pSer236) (BL2656), from rabbit (purified) (Prod. No. BET-A300-584A) | 50 ug |
BET-BP300-585 | Blocking Peptide for PAb to PRKRIR (25-75) (BL2254), from rabbit (purified) (Prod. No. BET-A300-585A) | 50 ug |
BET-BP300-586 | Blocking Peptide for PAb to PRKRIR (150-200) (BL2255), from rabbit (purified) (Prod. No. BET-A300-586A) | 50 ug |
BET-BP300-587 | Blocking Peptide for PAb to NonO (350-400) (human) (BL2553), from rabbit (purified) (Prod. No. BET-A300-587A) | 50 ug |
BET-BP300-588 | Blocking Peptide for PAb to Valosin-containing Protein (1-50) (BL2519), from rabbit (purified) (Prod. No. BET-A300-588A) | 50 ug |
BET-BP300-589 | Blocking Peptide for PAb to Valosin-containing Protein (750-806) (BL2520), from rabbit (purified) (Prod. No. BET-A300-589A) | 50 ug |
BET-BP300-590 | Blocking Peptide for PAb to Matrin-3 (475-500) (BL2525), from rabbit (purified) (Prod. No. BET-A300-590A) | 50 ug |
BET-BP300-591 | Blocking Peptide for PAb to Matrin-3 (800-847) (BL2526), from rabbit (purified) (Prod. No. BET-A300-591A) | 50 ug |
BET-BP300-592 | Blocking Peptide for PAb to Sec23IP (1-50) (human) (BL2564), from rabbit (purified) (Prod. No. BET-A300-592A) | 50 ug |
BET-BP300-593 | Blocking Peptide for PAb to Sec23IP (350-400) (human) (BL2565), from rabbit (purified) (Prod. No. BET-A300-593A) | 50 ug |
BET-BP300-594 | Blocking Peptide for PAb to Sec23IP (950-1000) (human) (BL2566), from rabbit (purified) (Prod. No. BET-A300-594A) | 50 ug |
BET-BP300-595 | Blocking Peptide for PAb to AF9 (200-250) (human) (BL2310), from rabbit (purified) (Prod. No. BET-A300-595A) | 50 ug |
BET-BP300-596 | Blocking Peptide for PAb to AF9 (250-300) (human) (BL2311), from rabbit (purified) (Prod. No. BET-A300-596A) | 50 ug |
BET-BP300-597 | Blocking Peptide for PAb to AF9 (525-568) (human) (BL2313), from rabbit (purified) (Prod. No. BET-A300-597A) | 50 ug |
BET-BP300-598P | Blocking Peptide for PAb to Estrogen Receptor alpha (human) (phosphorylated) (pSer305) (BL1665), from rabbit (purified) (Prod. No. BET-A300-598A) | 50 ug |
BET-BP300-599 | Blocking Peptide for PAb to GNL3 (1-50) (BL2856), from rabbit (purified) (Prod. No. BET-A300-599A) | 50 ug |
BET-BP300-600 | Blocking Peptide for PAb to GNL3 (500-549) (BL2858), from rabbit (purified) (Prod. No. BET-A300-600A) | 50 ug |
BET-BP300-601 | Blocking Peptide for PAb to CAP-D2 (1350-1401) (human) (BL2932), from rabbit (purified) (Prod. No. BET-A300-601A) | 50 ug |
BET-BP300-602 | Blocking Peptide for PAb to CAP-G (950-1015) (human) (BL2936), from rabbit (purified) (Prod. No. BET-A300-602A) | 50 ug |
BET-BP300-603 | Blocking Peptide for PAb to CAP-H (700-741) (human) (BL2940), from rabbit (purified) (Prod. No. BET-A300-603A) | 50 ug |
BET-BP300-604 | Blocking Peptide for PAb to CAP-D3 (1450-1507) (human) (BL2944), from rabbit (purified) (Prod. No. BET-A300-604A) | 50 ug |
BET-BP300-614 | Blocking Peptide for PAb to SKIV2L2 (100-150) (BL2548), from rabbit (purified) (Prod. No. BET-A300-614A) | 50 ug |
BET-BP300-615 | Blocking Peptide for PAb to SKIV2L2 (650-700) (human) (BL2549), from rabbit (purified) (Prod. No. BET-A300-615A) | 50 ug |
BET-BP300-616 | Blocking Peptide for PAb to DDX10 (500-550) (human) (BL3003), from rabbit (purified) (Prod. No. BET-A300-616A) | 50 ug |
BET-BP300-617 | Blocking Peptide for PAb to DDX10 (825-875) (human) (BL3004), from rabbit (purified) (Prod. No. BET-A300-617A) | 50 ug |
BET-A310-167A | BLM Antibody AbVantage Pack | 3 Vials |
BET-A310-168A | S6K2 Antibody AbVantage Pack | 2 Vials |
BET-A310-169A | Neurofibromin 2 Antibody AbVantage Pack | 2 Vials |
BET-A310-170A | WASP Antibody AbVantage Pack | 3 Vials |
BET-A310-171A | NonO Antibody AbVantage Pack | 2 Vials |
BET-A310-172A | RPS6 Antibody AbVantage Pack | 2 Vials |
BET-A310-173A | PRKRIR Antibody AbVantage Pack | 2 Vials |
BET-A310-174A | Valosin-containig Protein Antibody AbVantage Pack | 2 Vials |
BET-A310-175A | Matrin-3 Antibody AbVantage Pack | 2 Vials |
BET-A310-176A | Sec23IP Antibody AbVantage Pack | 3 Vials |
BET-A310-177A | AF9 Antibody AbVantage Pack | 3 Vials |
BET-A310-178A | GNL3 Antibody AbVantage Pack | 2 Vials |
BET-A310-179A | SKIV2L2 Antibody AbVantage Pack | 2 Vials |
BET-A310-180A | DDX10 Antibody AbVantage Pack | 2 Vials |